The co-op will
contribute to antibody discovery by learning and applying hybridomas generation
and high-throughput screening methodology. The opportunity would be mutually
beneficial, as the co-op would provide appreciated band-width while learning
about a core function in the field of biotechnology.
The Hybridoma could
use the extra band-width to meet high demands.
The co-op gets an introduction to the therapeutic mAb discovery process
and an introduction to the field of immunology.
- The co-op will contribute to therapeutic antibody
discovery by learning and applying hybridoma generation and high-throughput
- The opportunity would be beneficial by providing an
in-depth insight into a core function in the field of biotechnology and drug
- There will be an opportunity to contribute to the
development of new technologies, specifically, the development of advanced
animal immunization protocols and high-throughput screening protocols.
- This is also a great opportunity to learn fundamental
and advanced concepts in immunology and immuno-oncology, which has become a
very prominent discipline in modern medicine.
- Previous experience with mammalian cell culture,
ELISA, and cell and biochemical assay development is desired but not required.
- Co-Ops must be able to work
40 hours a week.
- Students must be able to
provide their own transportation to this location.
- Students must be legally
authorized to work in the United States and not require future sponsorship
for employment visa status (e.g. H1-B status) now or in the future.
United States-Pennsylvania-Spring HouseOrganization
Janssen Research & Development, LLC. (6084)Job Function